Medication-related osteonecrosis of the jaw: A review about etiology, risk factors, pathophysiology, and treatment
Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse effect of antiresorptive and antiangiogenic medication. MRONJ is considered when a patient has exposed bone in the jaw for more than 8 weeks and has a history of antiresorptive and antiangiogenic medication with a negative hist...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Wolters Kluwer Medknow Publications,
2020-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_e8f7c8c8c51748aebce8e9bb4a3a6fbd | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Sheetal Singar |e author |
| 700 | 1 | 0 | |a Ajay Pratap Singh Parihar |e author |
| 700 | 1 | 0 | |a Prashanthi Reddy |e author |
| 700 | 1 | 0 | |a Abhishek Maurya |e author |
| 700 | 1 | 0 | |a Vishal Bamaniya |e author |
| 245 | 0 | 0 | |a Medication-related osteonecrosis of the jaw: A review about etiology, risk factors, pathophysiology, and treatment |
| 260 | |b Wolters Kluwer Medknow Publications, |c 2020-01-01T00:00:00Z. | ||
| 500 | |a 0972-1363 | ||
| 500 | |a 10.4103/jiaomr.jiaomr_206_19 | ||
| 520 | |a Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse effect of antiresorptive and antiangiogenic medication. MRONJ is considered when a patient has exposed bone in the jaw for more than 8 weeks and has a history of antiresorptive and antiangiogenic medication with a negative history of radiotherapy. Antiresorptive and antiangiogenic medication do not independently cause necrosis of bone. Various systemic and local risk factors like dentoalveolar trauma and extraction play an important role in the development of MRONJ. MRONJ can be prevented by proper dental evaluation and by performing the required treatment before commencing antiresorptive and antiangiogenic medication. | ||
| 546 | |a EN | ||
| 690 | |a antiangiogenic drugs | ||
| 690 | |a antiresorptive drugs | ||
| 690 | |a mronj | ||
| 690 | |a osteonecrosis | ||
| 690 | |a Dentistry | ||
| 690 | |a RK1-715 | ||
| 690 | |a Medical physics. Medical radiology. Nuclear medicine | ||
| 690 | |a R895-920 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Journal of Indian Academy of Oral Medicine and Radiology, Vol 32, Iss 1, Pp 50-54 (2020) | |
| 787 | 0 | |n http://www.jiaomr.in/article.asp?issn=0972-1363;year=2020;volume=32;issue=1;spage=50;epage=54;aulast=Singar | |
| 787 | 0 | |n https://doaj.org/toc/0972-1363 | |
| 856 | 4 | 1 | |u https://doaj.org/article/e8f7c8c8c51748aebce8e9bb4a3a6fbd |z Connect to this object online. |